Form 483

BROOKS STERISCIENCE LIMITED Form 483, 2024-11-12

FDA issued a Form 483 to BROOKS STERISCIENCE LIMITED on 2024-11-12 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

BROOKS STERISCIENCE LIMITED · Vadodara, India · Issued November 12, 2024

Overview

  • 4 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

12 Nov 2024
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Teresa I Navas

12 Nov 2024
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Teresa I Navas

12 Nov 2024
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Teresa I Navas

12 Nov 2024
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Teresa I Navas

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere